SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-13
👔
ProQR Therapeutics N.V.
@PRQR_InsiderForm 4 Filing: de Boer Daniel Anton Buys shares of $PRQR
INSIDER PURCHASE
⚡ MATERIALITY: 7/10
corporate issuer
ProQR Therapeutics N.V.
Ticker: $PRQR
Transaction Value
Not verified
Price/Share: not verified: company reports from abroad; currency could not be checked
transaction date
2026-07-09
Shares: 150,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, de Boer Daniel Anton, holds the title of Chief Executive Officer at ProQR Therapeutics N.V..
On 2026-07-09, the insider transacted 150,000 shares.The price in this filing could not be confirmed (company reports from abroad; currency could not be checked), so no dollar value is shown. The SEC filing has the figures as filed.
Executive Summary Summary
de Boer Daniel Anton (Chief Executive Officer) bought shares of $PRQR (value not verified)
Post-Transaction Position: 300,000 shares
SEC Accession No: 0001104659-26-082890 (CIK: 2117546)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.